[1] HASBALCELIKOK G,AKSOYSAGIRLII P,ALTPAMAKULBEGIG,et al. Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment[J].Oncol Lett,2021,21(3):209.
[2] JING-WEN L,QIAN W. Correlation between expression of survivin and neoadjuvant chemotherapy in gastric cancer tissue[J].Electronic J Metabol Nutrit Cancer,2018,5(1):73-77.
[3] 李璠,李强,姚玮,等. lncRNA及其在胃癌发生发展中的作用和机制研究进展[J].山东医药 2019,59(16):85-88.
[4] 熊万成,郗玉玲,平贯芳,等. lncRNA PVT1在结直肠癌组织和细胞中的表达及其对顺铂化疗敏感性的影响及机制[J].中国肿瘤生物治疗杂志,2019,26(7):743-750.
[5] 刘荫华,姚宏伟,周斌,等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J].中国实用外科杂志,2017,37(1):6-9.
[6] EISENHAUER EA,THERASSE P,BOGAERTS J,et al. New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-247.
[7] 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2015版)[J].中华消化外科杂志,2015,14(10):783-799.
[8] LIVAK KJ,SCHMITTGEN TDL. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method[J].Methods,2001,25(4):402-408.
[9] JUN W,XUAN Z,WEN C,et al. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks.[J].Int J Cancer,2020,146(4):906-916.
[10] 高蕊,何东宁,王亚帝,等. 芦丁通过Notch信号通路抑制结肠癌细胞增殖[J].中国老年学杂志,2019,39(5):1192-1194.
[11] 陈颖,杨博文,包博文,等. DYRK2高表达介导结直肠癌奥沙利铂耐药[J].中国医科大学学报,2021,50(5):429-434.
[12] 潘雪峰,高春芳. LncRNA PVT1与恶性肿瘤治疗的研究进展[J].肿瘤学杂志,2019,25(2):145-151. |
2022, Vol. 39 
